Table of Contents  


Michael Rolf Mueler
Published in : HAMDAN MEDICAL JOURNAL ; Vol 9, No 1 (2016)
DOI : 10.7707/hmj.638


The last few years have witnessed dramatic changes in the diagnosis and therapy of lung cancer. Today, the universal concept of any therapeutic measure is a wider interpretation of the term ‘ targeted therapy’ . Previously, the armamentarium of systemic therapy comprised only a few chemotherapeutic agents. Today, the identification of specific mutations, and the development of specific drugs directed against these mutations, as well as of angiokinase inhibitors and immunotherapy, have dramatically improved survival rates and stimulated oncologists, scientists and industry.

View article in  :   PDF     HTML    

Add comment 

Home  Editorial Board  Search  Current Issue  Archive Issues  Announcements  Aims & Scope  About the Journal  How to Submit  Contact Us
Find out how to become a part of the HMJ  |   CLICK HERE >>
© Copyright 2012 - 2013 HMJ - HAMDAN Medical Journal. All Rights Reserved         Website Developed By Cedar Solutions INDIA